Vital Signs - Biomarkers in Clinical Trials - A Significant Competitive Advantage?

Vital Signs - Biomarkers in Clinical Trials - A Significant Competitive Advantage?

 

RELEASE DATE
09-Oct-2006
REGION
North America
Research Code: 9561-00-17-00-00
SKU: HC00455-NA-MR_03927
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00455-NA-MR_03927

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on October 9, 2006, provides a strategic overview and discussion of the use of biomarkers in clinical trials. Additionally, an emerging company profile is provided for Dendritic Nanotechnologies Inc., a company that specializes in the development and commercialization of dendrimers and dendritic polymers. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of September 25 - September 29, 2006.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on October 9, 2006, provides a strategic overview and discussion of the use of biomarkers in clinical trials. Additionally, an emerging company profile is provided for Dendritic Nanotechnologies Inc., a company that specializes in the development and commercialization of dendrimers and dendritic polymers. Reimbursement and regulatory news from the FDA and CMS is also provided for the week of September 25 - September 29, 2006.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-17-00-00
Is Prebook No